Biotech firm Edgewise Therapeutics said on Monday it would sell its experimental muscular dystrophy drug and related business to France’s Servier for up to $2.65 billion. The French drugmaker ...
Browsing Tag: Dystrophy
1
2
3
PAK ALERT NEWS
Biotech firm Edgewise Therapeutics said on Monday it would sell its experimental muscular dystrophy drug and related business to France’s Servier for up to $2.65 billion. The French drugmaker ...